Smith Julie — SEC Form 4 filings
SEC reporting owner CIK 1557928. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-05.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-05-23 to 2026-06-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 3 filings — 207,627 shares, $8,067,958 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 54,514 shares @ $38.13 ($2,078,619) in EXELIXIS, INC., filed 2025-02-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| EXELIXIS, INC. (EXEL) | Director | 7 | — | 6 legs · 207,627 sh · $8,067,958 | 17 |
| Stoke Therapeutics, Inc. (STOK) | Director | 3 | — | — | 3 |
Form 4 filings — Smith Julie
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-05 | 4 | Stoke Therapeutics, Inc. (STOK) | Grant/award (A): 17,786 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | EXELIXIS, INC. (EXEL) | Grant/award (A): 8,367 @ $0 | EDGAR |
| 2026-02-19 | 4 | EXELIXIS, INC. (EXEL) | Option exercise (M): 42,422 @ $18.19 · Sale (S): 42,422 @ $43.33 · Option exercise (M): 44,087 @ $19.39 · Sale (S): 44,087 @ $44.50 · Option exercise (M): 20,030 @ $21.69 · Sale (S): 20,030 @ $44.30 · +3 more | EDGAR |
| 2025-06-04 | 4 | Stoke Therapeutics, Inc. (STOK) | Grant/award (A): 29,747 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | EXELIXIS, INC. (EXEL) | Grant/award (A): 9,812 @ $0 | EDGAR |
| 2025-02-28 | 4 | EXELIXIS, INC. (EXEL) | Option exercise (M): 31,167 @ $20.50 · Option exercise (M): 23,347 @ $19.77 · Sale (S): 54,514 @ $38.13 · Option exercise (M): 19,294 @ $19.77 · Sale (S): 19,294 @ $37.62 · Option exercise (M): 31,167 (derivative) @ $0 · +2 more | EDGAR |
| 2024-08-15 | 4 | EXELIXIS, INC. (EXEL) | Other (J): 4,682 @ $0 | EDGAR |
| 2024-06-07 | 4 | Stoke Therapeutics, Inc. (STOK) | Grant/award (A): 7,639 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | EXELIXIS, INC. (EXEL) | Grant/award (A): 10,015 @ $0 · Grant/award (A): 20,030 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | EXELIXIS, INC. (EXEL) | Sale (S): 27,280 @ $21.12 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1557928 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →